Up-regulation of CD64-expressing monocytes with impaired FcγR function reflects disease activity in polyarticular psoriatic arthritis

References

• Gladman DD. Psoriatic arthritis. Dermatol Ther 2009;22:40–55.
   PubMed Web of Science ®Google Scholar
• Van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006;65:1551–7.
   PubMed Web of Science ®Google Scholar
• Kanekura T, Kawabata H, Maruyama I, Kanzaki T. Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;50:242–6.
   PubMed Web of Science ®Google Scholar
• Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001;69:11–20.
   PubMed Web of Science ®Google Scholar
• Canete JD, Santiago B, Cantaert T, Sanmarti R, Palacin A, Celis R, et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis 2007;66:720–6.
   PubMed Web of Science ®Google Scholar
• Laurent MR, Panayi GS, Shepherd P. Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis 1981;40:66–9.
   PubMed Web of Science ®Google Scholar
• Johnson SR, Schentag CT, Gladman DD. Autoantibodies in biological agent naive patients with psoriatic arthritis. Ann Rheum Dis 2005;64:770–2.
   PubMed Web of Science ®Google Scholar
• Colmegna I, Sainz B Jr, Citera G, Maldonado-Cocco JA, Garry RF, Espinoza LR. Anti-20S proteasome antibodies in psoriatic arthritis. J Rheumatol 2008;35:674–6.
   PubMed Web of Science ®Google Scholar
• Chou CL, Wu MJ, Yu CL, Lu MC, Hsieh SC, Wu TH et al. Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis. Clin Rheumatol 2010;29:875–81.
   PubMed Web of Science ®Google Scholar
• Shibata S, Tada Y, Komine M, Hattori N, Osame S, Kanda N, et al. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci 2009;53:34–9.
   PubMed Web of Science ®Google Scholar
• Tarkowski A, Nilsson LA. Rheumatoid factors in psoriatic arthropathy and in Waaler-Rose negative rheumatoid arthritis. Rheumatol Int 1984;4:115–17.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008;8:34–47.
   PubMed Web of Science ®Google Scholar
• Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med 2000;191:1611–16.
   PubMed Web of Science ®Google Scholar
• Nandakumar KS, Andrén M, Martinsson P, Bajtner E, Hellström S, Holmdahl R, et al. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur J Immunol 2003; 33:2269–77.
   PubMed Web of Science ®Google Scholar
• Thorvaldsson L, Fuchs D, Magnusson S, Kleinau S. IgG immune complex-binding in macrophages from arthritis-susceptible and arthritis-resistant mice following collagen type II immunization. Scand J Immunol 2006;63:347–54.
   PubMed Web of Science ®Google Scholar
• Monteiro RC. Role of IgA and IgA fc receptors in inflammation. J Clin Immunol 2010;30:1–9.
   PubMed Web of Science ®Google Scholar
• Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffie C, et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005;22:31–42.
   PubMed Web of Science ®Google Scholar
• Wolf HM, Hauber I, Gulle H, Samstag A, Fischer MB, Ahmad RU, et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Clin Exp Immunol 1996;105:537–43.
   PubMed Web of Science ®Google Scholar
• Boltz-Nitulescu G, Willheim M, Spittler A, Leutmezer F, Tempfer C, Winkler S. Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1 alpha,25-dihydroxyvitamin D3 and cytokines. J Leukoc Biol 1995;58:256–62.
   PubMed Web of Science ®Google Scholar
• Schiff DE, Rae J, Martin TR, Davis BH, Curnutte JT. Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood 1997;90:3187–94.
   PubMed Web of Science ®Google Scholar
• Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005;115:2914–23.
   PubMed Web of Science ®Google Scholar
• Reterink TJ, Levarht EW, Klar-Mohamad N, Van Es LA, Daha MR. Transforming growth factor-beta 1 (TGF-beta 1) down-regulates IgA Fc-receptor (CD89) expression on human monocytes. Clin Exp Immunol 1996;103:161–6.
   PubMed Web of Science ®Google Scholar
• Chiamolera M, Launay P, Montenegro V, Rivero MC, Velasco IT, Monteiro RC. Enhanced expression of Fc alpha receptor I on blood phagocytes of patients with gram-negative bacteremia is associated with tyrosine phosphorylation of the FcR-gamma subunit. Shock 2001;16:344–8.
   PubMed Web of Science ®Google Scholar
• Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000;19:101–5.
   PubMed Web of Science ®Google Scholar
• Cordiali-Fei P, Ardigo M, Mastroianni A, Giuliani A, D’ Agosto G, Bordignon V, et al. Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment. Int J Immunopathol Pharmacol 2008;21:643–9.
   PubMed Web of Science ®Google Scholar
• Taylor WJ, Helliwell PS. Development of diagnostic criteria for psoriatic arthritis: methods and process. Curr Rheumatol Rep 2004;6:299–305.
   PubMedGoogle Scholar
• Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S64–85.
   PubMed Web of Science ®Google Scholar
• Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978;157:238–44.
   PubMedGoogle Scholar
• Stohlawetz P, Hahn P, Köller M, Hauer J, Resch H, Smolen J, et al. Immunophenotypic characteristics of monocytes in elderly subjects. Scand J Immunol 1998;48:324–6.
   PubMed Web of Science ®Google Scholar
• Prokopec KE, Rhodiner M, Matt P, Lindqvist U, Kleinau S. Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis. Clin Immunol 2010;13:322–9.
   Web of Science ®Google Scholar
• Lindqvist U, Alenius GM, Husmark T, Theander E, Holmström G, Larsson PT, et al. The Swedish Early Psoriatic Arthritis Register – 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008;35:668–73.
   PubMed Web of Science ®Google Scholar
• Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004;50:1967–75.
   PubMed Web of Science ®Google Scholar
• Li Y, Lee PY, Sobel ES, Narain S, Satoh M, Segal MS, et al. Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther 2009;11:R6.
   PubMedGoogle Scholar
• Hepburn AL, Mason JC, Davies KA. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) 2004;43:547–54.
   PubMed Web of Science ®Google Scholar
• Torsteinsdottir I, Arvidsson NG, Hällgren R, Håkansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999;115: 554–60.
   PubMed Web of Science ®Google Scholar
• Wijngaarden S, Van Roon JA, Van De Winkel JG, Bijlsma JW, Lafeber FP. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment. Rheumatology (Oxford) 2005;44: 729–34.
   PubMed Web of Science ®Google Scholar
• Van Vuuren AJ, Van Roon JA, Walraven V, Stuij I, Harmsen MC, Mclaughlin PM, et al. CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model. J Immunol 2006;176:5833–8.
   PubMed Web of Science ®Google Scholar
• Ellsworth JL, Hamacher N, Harder B, Bannink K, Bukowski TR, Byrnes-Blake K, et al. Recombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis. J Immunol 2009;182:7272–9.
   PubMed Web of Science ®Google Scholar
• Mancardi DA1, Albanesi M, Jönsson F, Iannascoli B, Van Rooijen N, Kang X, et al. The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 2013;121: 1563–73.
   PubMed Web of Science ®Google Scholar
• Van der Poel CE, Karssemeijer RA, Boross P, van der Linden JA, Blokland M, van de Winkel JG, et al. Cytokine-induced immune complex binding to the high-affinity IgG receptor, FcγRI, in the presence of monomeric IgG. Blood 2010;116:5327–33.
   PubMed Web of Science ®Google Scholar
• Mackinnon SK, Starkebaum G. Monocyte Fc receptor function in rheumatoid arthritis. Enhanced cell-binding of IgG induced by rheumatoid factors. Arthritis Rheum 1987;30:498–506.
   PubMed Web of Science ®Google Scholar
• Lin G, Li J. Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int 2010;30:837–40.
   PubMed Web of Science ®Google Scholar
• Cohen PL, Cheek RL, Hadler JA, Yount WJ, Eisenberg RA. The subclass distribution of human IgG rheumatoid factor. J Immunol 1987;139:1466–71.
   PubMed Web of Science ®Google Scholar
• Munz OH, Sela S, Baker BS, Griffiths CE, Powles AV, Fry L. Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res 2010;302:495–8.
   PubMed Web of Science ®Google Scholar
• Hall RP, Gerber LH, Lawley TJ. IgA-containing immune complexes in patients with psoriatic arthritis. Clin Exp Rheumatol 1984;2:221–5.
   PubMed Web of Science ®Google Scholar
• Sierakowski S, Cutolo M. Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease. Scand J Rheumatol Suppl 2011;125:1–5.
   PubMedGoogle Scholar
• Hamre R, Farstad IN, Brandtzaeg P, Morton HC. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand J Immunol 2003;57:506–16.
   PubMed Web of Science ®Google Scholar
• Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther 2006;8:R152.
   PubMed Web of Science ®Google Scholar